6Promrat K, Lutchman G, Uwaifo GI, et al. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis [ J ]. Hepatology, 2004,39( 1 ) :188 - 196.
7Guruprasad P, James A, Philip V, et al. Randomized, placebocontrolled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis [ J ]. Gastroenterology, 2008, 135 ( 4 ) : 1176-1184.
8Renata B, Stephen A, Kenneth B, et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis [ J ]. N Engl J Med,2006,355(2) :2297 -2307.
9Tetri-Neuschwander BA, Brunt EM, Wehmeier KR, et al. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone [ J ]. Hepatology, 2003,38 (4) :1008 - 1017.
10Filiz Akyuz, Kadir Demir, Sadakatozdil, et al. The effects of rosiglitazone, metformin, and diet with exercise in nonalcoholic fatty liver disease[J]. Dig Dis Sci,2007,52(9) :2359 -2367.
